Latest PRCT news and sentiment

PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20

PRCT Investment Alert - PROCEPT BioRobotics Corporation Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action

This article is an investment alert from Robbins LLP, notifying stockholders of PROCEPT BioRobotics Corporation (PRCT) who have experienced significant losses to contact the firm. The alert suggests that Robbins LLP is providing information regarding a securities class action related to PRCT. The full content of the article is unavailable, as the provided text appears to be a website's navigation and footer information rather than the article itself.

PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026 Deadline

Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) for alleged violations of the Securities Exchange Act of 1934. The lawsuit, captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, claims that Procept made materially false and/or misleading statements regarding its business, operations, and financial condition between February 28, 2024, and February 25, 2026. Investors who suffered substantial losses are encouraged to seek appointment as lead plaintiff before the September 22, 2026, deadline.

PRCT FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

The Rosen Law Firm is reminding purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024, and February 25, 2026, of the September 22, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that PROCEPT made materially false and misleading statements regarding its discount program, which artificially inflated sales and revenues by encouraging bulk orders beyond demand, leading to overstocking and significant financial harm. Investors who purchased during the Class Period may be entitled to compensation and are encouraged to contact the law firm to join the class action.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT

PROCEPT (PRCT) Financial Update: EPS Misses Its Estimate in the Available Record; Market Reaction: The Stock Gains 4.58% in Latest Trading - Guidance Revision Trend

PROCEPT BioRobotics (PRCT) Faces Lawsuit Scrutiny After Revenue Claims So Is It A Buying Opportunity

PROCEPT BioRobotics (PRCT) is facing class-action lawsuits alleging misleading investors on sales and inflated revenue, contributing to a significant stock decline over the past year despite a recent rebound. While one narrative suggests the stock is undervalued at $25.26, a Simply Wall St discounted cash flow model indicates it may be overvalued at its current price of $21.68, raising questions about whether now is a good entry point. Investors are advised to review underlying data to form their own conclusions given the split sentiment and legal uncertainties.

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC (KSF) is reminding investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) with substantial losses that they have until September 22, 2026, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that Procept failed to disclose material information regarding excess handpiece inventory, which led to a significant decline in sales and an over 18% drop in stock price after the company announced its Q4 2025 earnings. Investors who purchased shares between February 28, 2024, and February 25, 2026, are encouraged to contact KSF for more information on their legal rights.

PRCT DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM,

The Rosen Law Firm is reminding investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) with losses exceeding $100K to secure legal counsel by the September 22, 2026, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that PROCEPT made false and misleading statements about an undisclosed discount program that artificially inflated sales and revenue. Investors who purchased common stock between February 28, 2024, and February 25, 2026, may be entitled to compensation.

PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that Procept misled investors by failing to disclose an extensive discount program that artificially inflated sales and revenues, leading to overstocked inventory and ultimately causing investor damages. Investors have until September 22, 2026, to apply for lead plaintiff status.

PRCT INVESTOR DEADLINE: RGRD Law Files Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (PRCT) on behalf of investors who purchased stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements by failing to disclose an extensive discount program that artificially inflated sales and revenues, leading to a significant overstock of handpiece units. Investors with substantial losses have until September 22, 2026, to seek appointment as lead plaintiff in the case.

Kaplan Fox Announces a Securities Class Action Filed Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) - Lead Plaintiff Deadline is September 22, 2026

Kaplan Fox & Kilsheimer LLP has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated its reported U.S. handpiece unit sales and revenues by concealing that its discount program caused handpiece orders to materially exceed procedures. Investors who suffered losses are encouraged to contact Kaplan Fox, with a lead plaintiff deadline of September 22, 2026.

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) due to alleged undisclosed inventory issues and a significant stock decline. The lawsuit claims PROCEPT withheld crucial information about handpiece sales practices, using an extensive discount program that artificially inflated sales by encouraging bulk orders beyond customer demand. Investors reportedly learned the truth through a series of disclosures that led to a substantial drop in share price.

PRCT DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

The Rosen Law Firm is reminding purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock during the Class Period (February 28, 2024, and February 25, 2026) of an important lead plaintiff deadline of September 22, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements regarding its discount program, which artificially inflated sales and revenues by pulling forward future sales, leading to overstocking and an inability to meet stated sales guidance. Investors who bought PROCEPT common stock during this period may be entitled to compensation and are encouraged to contact the firm.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against PROCEPT BioRobotics Corporation (PRCT)

Bernstein Liebhard LLP has announced the filing of a securities fraud class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased shares between February 28, 2024, and February 25, 2026. The lawsuit alleges that the company made false and misleading statements about its business, growth prospects, and financial stability, leading to inflated stock prices and subsequent investor losses. Investors are encouraged to join the class action by September 22, 2026.

Robbins LLP Encourages PRCT Shareholders With Significant Losses to Contact the Firm for Information About the Class Action Against PROCEPT BioRobotics Corporation

PRCT DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM,

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who experienced losses exceeding $100,000 to secure legal counsel before the September 22, 2026, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that PROCEPT made materially false and misleading statements regarding an undisclosed discount program that artificially inflated sales and revenues, leading to an overstocking of products and significant financial harm. Investors who purchased PROCEPT common stock between February 28, 2024, and February 25, 2026, may be entitled to compensation.